Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plecanatide Dose-Ranging Study in CIC
NCT01429987Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Oct 2011
- Primary completion
- Dec 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of plecanatide in chronic idiopathic constipation (CIC), sponsored by Valeant Pharmaceuticals. Started Oct 2011; status: completed.
02
Drugs
plecanatide
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT01429987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01429987.